Ignite Creation Date:
2025-12-25 @ 3:04 AM
Ignite Modification Date:
2026-02-25 @ 5:52 PM
Study NCT ID:
NCT01369433
Status:
TERMINATED
Last Update Posted:
2020-09-01
First Post:
2010-03-04
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Rollover Protocol to Allow Continued Access to Tivozanib (AV 951) for Subjects Enrolled in Other Tivozanib Protocols
Sponsor:
AVEO Pharmaceuticals, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2010-06
Start Date Type:
None
Primary Completion Date:
2015-06
Primary Completion Date Type:
ACTUAL
Completion Date:
2015-10
Completion Date Type:
ACTUAL
First Submit Date:
2010-03-04
First Submit QC Date:
None
Study First Post Date:
2011-06-09
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2020-07-06
Results First Submit QC Date:
None
Results First Post Date:
2020-09-01
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-08-17
Last Update Post Date:
2020-09-01
Last Update Post Date Type:
ACTUAL